FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Product Approval Information - Licensing Action

horizontal rule

Product name: Anticoagulant Sodium Citrate 4% w/v Solution, U.S.P.
Manufacturer: Haemonetics Corporation, Braintree, MA
Indication for Use: Only with automated apheresis devices in the collection of human plasma or in performing therapeutic plasma exchange procedures
Approval Date: 3/3/2000
Type of submission: New Drug Application

horizontal rule

Approval Letter (PDF), (Text)

SBA (PDF), (Text)

 

Updated March 5, 2001
 
horizontal rule

CBER Home Page | CBER A-Z Index | CBER Search | Contact CBER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA / Center for Biologics Evaluation and Research